Related references
Note: Only part of the references are listed.Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model
Kimberley A. Stannard et al.
CANCER LETTERS (2010)
Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
Victor L. Thijssen et al.
CANCER RESEARCH (2010)
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
Rajeev K. Shrimali et al.
CANCER RESEARCH (2010)
Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells
Xu-Yun Zhao et al.
CARCINOGENESIS (2010)
Mitochondria and Hypoxic Signaling A New View
Robert O. Poyton et al.
HYPOXIA AND CONSEQUENCES FROM MOLECULE TO MALADY (2009)
Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses
Marie Le Mercier et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Characterisation of Oxidized Recombinant Human Galectin-1
Stacy A. Scott et al.
PROTEIN AND PEPTIDE LETTERS (2009)
Galectin 1 Proangiogenic and Promigratory Effects in the Hs683 Oligodendroglioma Model Are Partly Mediated through the Control of BEX2 Expression
Marie Le Mercier et al.
NEOPLASIA (2009)
The galectin profile of the endothelium - Altered expression and localization in activated and tumor endothelial cells
Victor L. Thijssen et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Anti-angiogenesis: making the tumor vulnerable to the immune system
Arjan W. Griffioen
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking
Lucy V. Norling et al.
FASEB JOURNAL (2008)
Galectin-Inhibitory Thiodigalactoside Ester Derivatives Have Antimigratory Effects in Cultured Lung and Prostate Cancer Cells
Tamara Delaine et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Juliana Hamzah et al.
NATURE (2008)
The determination of the levels of circulating galectin-1 and-3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy
Sven Saussez et al.
ORAL ONCOLOGY (2008)
Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma
Wei-Fan Chiang et al.
ORAL ONCOLOGY (2008)
Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease
Sven Saussez et al.
THYROID (2008)
Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer
Mariana Salatino et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: The role of oxidative stress
Lan-Feng Dong et al.
CANCER RESEARCH (2007)
Galectins in the tumor endothelium: opportunities for combined cancer therapy
Victor L. J. L. Thijssen et al.
BLOOD (2007)
Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model
Veronique Mathieu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Studies of arginine-arene interactions through synthesis and evaluation of a series of galectin-binding aromatic lactose esters
Ian Cumpstey et al.
CHEMBIOCHEM (2007)
Galectin-1:: a key effector of regulation mediated by CD4+CD25+ T cells
Marina I. Garin et al.
BLOOD (2007)
Galectin-1: a small protein with major functions
Isabelle Camby et al.
GLYCOBIOLOGY (2006)
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
Victor L. J. L. Thijssen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site
Victor Appay et al.
JOURNAL OF IMMUNOLOGY (2006)
Galectin-1: A link between tumor hypoxia and tumor immune privilege
QT Le et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Galectin-1 as a potential cancer target
GA Rabinovich
BRITISH JOURNAL OF CANCER (2005)
Galectins as modulators of tumour progression
FT Liu et al.
NATURE REVIEWS CANCER (2005)
C-2-symmetrical thiodigalactoside bis-benzamido derivatives as high-affinity inhibitors of galectin-3: efficient lectin inhibition through double arginine-arene interactions
I Cumpstey et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege
N Rubinstein et al.
CANCER CELL (2004)
Tumor microvasculature as a barrier to antitumor immunity
Q Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Anti-tumor activity of the novel angiogenesis inhibitor anginex
RPM Dings et al.
CANCER LETTERS (2003)
Partial identification by site-directed mutagenesis of a cell growth inhibitory site on the human galectin-1 molecule
K Scott et al.
BMC CELL BIOLOGY (2002)
Anginex, a designed peptide that inhibits angiogenesis
AW Griffioen et al.
BIOCHEMICAL JOURNAL (2001)
Hypoxia and oxidative stress in breast cancer - Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer
NS Brown et al.
BREAST CANCER RESEARCH (2001)
Galectin-1 induces partial TCR ζ-chain phosphorylation and antagonizes processive TCR signal transduction
CD Chung et al.
JOURNAL OF IMMUNOLOGY (2000)
Oxidized galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties
Y Inagaki et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
